Stocks News

LAST PRICE
285.0200
TODAY'S CHANGE (%)
Trending Up3.0100 (1.0673%)

Bid / Lots
284.6200/ 4
Ask / Lots
285.4100/ 4
Open / Previous Close
283.0700 / 282.0100
Day Range
Low 282.9100
High 286.7300
52 Week Range
Low 261.5900
High 431.7900
Volume
89,014
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Yesterday
- Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group, from 9:00AM ET on Thursday May 30, 2024 by Business Wire
  9:00AM ET on Thursday May 30, 2024 by Business Wire
  Companies Mentioned: BIO.B
  Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Anette Engelhardt will join the company as its new Executive Vice President and President of the Clinical Diagnostics Group, effective June 10, 2024.
- Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group, from 9:00AM ET on Thursday May 30, 2024 by Dow Jones
  9:00AM ET on Thursday May 30, 2024 by Dow Jones
  Companies Mentioned: BIO, BIO.B
  HERCULES, Calif.--(BUSINESS WIRE)--May 30, 2024--
  Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Anette Engelhardt will join the company as its new Executive Vice President and President of the Clinical Diagnostics Group, effective June 10, 2024.
May 23, 2024
- Bio-Rad's Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference, from 4:15PM ET on Thursday May 23, 2024 by Business Wire
  4:15PM ET on Thursday May 23, 2024 by Business Wire
  Companies Mentioned: BIO.B
  Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that its Chief Executive Officer Norman Schwartz and Chief Financial Officer Roop K. Lakkaraju will participate in a fireside chat event during the Jefferies Global Healthcare Conference on Thursday, June 6, 2024, at 10:30 AM Eastern Time (7:30 AM Pacific Time).
- Bio-Rad's Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference, from 4:15PM ET on Thursday May 23, 2024 by Dow Jones
  4:15PM ET on Thursday May 23, 2024 by Dow Jones
  Companies Mentioned: BIO, BIO.B
  HERCULES, Calif.--(BUSINESS WIRE)--May 23, 2024--
  Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that its Chief Executive Officer Norman Schwartz and Chief Financial Officer Roop K. Lakkaraju will participate in a fireside chat event during the Jefferies Global Healthcare Conference on Thursday, June 6, 2024, at 10:30 AM Eastern Time (7:30 AM Pacific Time).
May 8, 2024
- UBS Adjusts Price Target on Bio-Rad Laboratories to $385 From $420, Maintains Buy Rating, from 10:19AM ET on Wednesday May 08, 2024 by MT Newswires
  10:19AM ET on Wednesday May 08, 2024 by MT Newswires
  Companies Mentioned: BIO
  10:19 AM EDT, 05/08/2024 (MT Newswires) -- Bio-Rad Laboratories (BIO) has an average outperform rating and price target range of $365 to $441, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research f...

Today
- Masimo's Third Settlement Offer Rejected by Politan Capital Management, from 4 hours ago by MT Newswires
  4 hours ago by MT Newswires
  Companies Mentioned: MASI
- Masimo Announces Nomination of Independent Candidate to the Board of Directors, from 6 hours ago by Business Wire
  6 hours ago by Business Wire
  Companies Mentioned: MASI
Yesterday
- Lowey Dannenberg, P.C. is Investigating Masimo Corporation (NASDAQ: MASI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm, from 19 hours ago by GlobeNewswire
  19 hours ago by GlobeNewswire
  Companies Mentioned: MASI
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Masimo Corporation - MASI, from 20 hours ago by PR Newswire
  20 hours ago by PR Newswire
  Companies Mentioned: MASI
May 29, 2024
- ROSEN, A TOP RANKED LAW FIRM, Encourages Masimo Corporation Investors to Inquire About Securities Class Action Investigation - MASI, from 3:34PM ET on Wednesday May 29, 2024 by Newsfile
  3:34PM ET on Wednesday May 29, 2024 by Newsfile
  Companies Mentioned: MASI
- Masimo to Present in Jefferies Global Healthcare Conference, from 9:00AM ET on Wednesday May 29, 2024 by Business Wire
  9:00AM ET on Wednesday May 29, 2024 by Business Wire
  Companies Mentioned: MASI
- BTIG Adjusts Globus Medical's Price Target to $72 From $63, Keeps Buy Rating, from 8:08AM ET on Wednesday May 29, 2024 by MT Newswires
  8:08AM ET on Wednesday May 29, 2024 by MT Newswires
  Companies Mentioned: GMED
- Medable and Masimo Partner to Bring Best-in-Class Wearable Devices to Clinical Research, Capturing Rich Subjective and Objective Data, from 7:00AM ET on Wednesday May 29, 2024 by Business Wire
  7:00AM ET on Wednesday May 29, 2024 by Business Wire
  Companies Mentioned: MASI
May 28, 2024
- ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Masimo Corporation Investors to Inquire About Securities Class Action Investigation - MASI, from 5:05PM ET on Tuesday May 28, 2024 by PR Newswire
  5:05PM ET on Tuesday May 28, 2024 by PR Newswire
  Companies Mentioned: MASI
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Masimo Corporation - MASI, from 3:39PM ET on Tuesday May 28, 2024 by GlobeNewswire
  3:39PM ET on Tuesday May 28, 2024 by GlobeNewswire
  Companies Mentioned: MASI

Bio Rad Laboratories Inc
NYSE:BIOUnited States

Search Criteria

Yesterday

Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group, from 9:00AM ET on Thursday May 30, 2024 by Business Wire

Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group, from 9:00AM ET on Thursday May 30, 2024 by Dow Jones

May 23, 2024

Bio-Rad's Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference, from 4:15PM ET on Thursday May 23, 2024 by Business Wire

Bio-Rad's Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference, from 4:15PM ET on Thursday May 23, 2024 by Dow Jones

May 8, 2024

UBS Adjusts Price Target on Bio-Rad Laboratories to $385 From $420, Maintains Buy Rating, from 10:19AM ET on Wednesday May 08, 2024 by MT Newswires

Peers Headlines

Today

Masimo's Third Settlement Offer Rejected by Politan Capital Management, from 4 hours ago by MT Newswires

Masimo Announces Nomination of Independent Candidate to the Board of Directors, from 6 hours ago by Business Wire

Yesterday

Lowey Dannenberg, P.C. is Investigating Masimo Corporation (NASDAQ: MASI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm, from 19 hours ago by GlobeNewswire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Masimo Corporation - MASI, from 20 hours ago by PR Newswire

May 29, 2024

ROSEN, A TOP RANKED LAW FIRM, Encourages Masimo Corporation Investors to Inquire About Securities Class Action Investigation - MASI, from 3:34PM ET on Wednesday May 29, 2024 by Newsfile

Masimo to Present in Jefferies Global Healthcare Conference, from 9:00AM ET on Wednesday May 29, 2024 by Business Wire

BTIG Adjusts Globus Medical's Price Target to $72 From $63, Keeps Buy Rating, from 8:08AM ET on Wednesday May 29, 2024 by MT Newswires

Medable and Masimo Partner to Bring Best-in-Class Wearable Devices to Clinical Research, Capturing Rich Subjective and Objective Data, from 7:00AM ET on Wednesday May 29, 2024 by Business Wire

May 28, 2024

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Masimo Corporation Investors to Inquire About Securities Class Action Investigation - MASI, from 5:05PM ET on Tuesday May 28, 2024 by PR Newswire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Masimo Corporation - MASI, from 3:39PM ET on Tuesday May 28, 2024 by GlobeNewswire